<VariationArchive VariationID="1174013" VariationName="Single allele" VariationType="Deletion" Accession="VCV001174013" Version="1" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2021-06-26" MostRecentSubmission="2021-06-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1163111" VariationID="1174013">
      <GeneList>
        <Gene Symbol="ATM" FullName="ATM serine/threonine kinase" GeneID="472" HGNC_ID="HGNC:795" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="108223067" stop="108369102" display_start="108223067" display_stop="108369102" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="108093558" stop="108239825" display_start="108093558" display_stop="108239825" Strand="+" />
          </Location>
          <OMIM>607585</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATM">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ATM">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>Single allele</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="108098332" stop="108236255" display_start="108098332" display_stop="108236255" variantLength="137924" alternateAllele="-" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.108098332_108236255del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.108098332_108236255del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="Single allele AND Ovarian neoplasm" Accession="RCV001527475" Version="2">
        <ClassifiedConditionList TraitSetID="6377">
          <ClassifiedCondition DB="MedGen" ID="C0919267">Ovarian neoplasm</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-03-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="Single allele AND multiple conditions" Accession="RCV001527477" Version="2">
        <ClassifiedConditionList TraitSetID="68094">
          <ClassifiedCondition DB="MedGen" ID="C0032463">Acquired polycythemia vera</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0854924">Endometrial serous adenocarcinoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-03-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-03-19" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2021-06-26" MostRecentSubmission="2021-06-26">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6377" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5713" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ovarian Neoplasms</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ovarian neoplasm</ElementValue>
                <XRef ID="HP:0100615" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0021068" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ovarian tumor</ElementValue>
                <XRef ID="HP:0100615" DB="Human Phenotype Ontology" />
                <XRef ID="123843001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplasm of ovary</ElementValue>
                <XRef ID="123843001" DB="SNOMED CT" />
              </Name>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2012">
                <ID Source="PubMed">22964825</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2013">
                <ID Source="PubMed">23188549</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2021">
                <ID Source="PubMed">33410258</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2018">
                <ID Source="PubMed">29450531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg122</URL>
                <CitationText>UK NICE Clinical guideline (CG122), Ovarian cancer: recognition and initial management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer, 2024</CitationText>
              </Citation>
              <XRef ID="C0919267" DB="MedGen" />
              <XRef ID="D010051" DB="MeSH" />
              <XRef ID="MONDO:0021068" DB="MONDO" />
              <XRef Type="primary" ID="HP:0100615" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="68094" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="3361" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Suspected polycythemia vera</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycythemia vera</ElementValue>
                <XRef ID="Polycythemia+vera/5826" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycythemia vera, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Acquired polycythemia vera</ElementValue>
                <XRef ID="MONDO:0009891" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polycythemia rubra vera</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PV</ElementValue>
                <XRef Type="MIM" ID="263300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PRV</ElementValue>
                <XRef Type="MIM" ID="263300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7422" />
                <XRef ID="7422" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/mpn.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Myeloproliferative Neoplasms, 2023</CitationText>
              </Citation>
              <XRef ID="729" DB="Orphanet" />
              <XRef ID="C0032463" DB="MedGen" />
              <XRef ID="D011087" DB="MeSH" />
              <XRef ID="MONDO:0009891" DB="MONDO" />
              <XRef Type="MIM" ID="263300" DB="OMIM" />
            </Trait>
            <Trait ID="46897" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Uterine corpus serous adenocarcinoma</ElementValue>
                <XRef ID="MONDO:0003629" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Endometrial serous adenocarcinoma</ElementValue>
                <XRef ID="MONDO:0006196" DB="MONDO" />
              </Name>
              <XRef ID="C0854924" DB="MedGen" />
              <XRef ID="MONDO:0006196" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3425761" SubmissionDate="2021-05-19" DateLastUpdated="2021-06-26" DateCreated="2021-06-26">
        <ClinVarSubmissionID localKey=":Chr.11_108098332_108236255_-_Deletion|MedGen:C0032463;C0854924" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001738495" DateUpdated="2021-06-26" DateCreated="2021-06-26" Type="SCV" Version="1" SubmitterName="University Health Network, Princess Margaret Cancer Centre" OrgID="507285" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SecondaryFinding">yes</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="-" start="108098332" stop="108236255" variantLength="137924" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0032463" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0854924" Type="CUI" />
          </Trait>
        </TraitSet>
        <Comment>This is a full deletion of ATM. This whole gene deletion was detected by next generation sequencing of genomic DNA (gDNA) and confirmed by MLPA</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB9611268</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3425759" SubmissionDate="2021-05-19" DateLastUpdated="2021-06-26" DateCreated="2021-06-26">
        <ClinVarSubmissionID localKey=":Chr.11_108098332_108236255_-_Deletion|OMIM:167000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001738493" DateUpdated="2021-06-26" DateCreated="2021-06-26" Type="SCV" Version="1" SubmitterName="University Health Network, Princess Margaret Cancer Centre" OrgID="507285" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>somatic</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SecondaryFinding">yes</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ATM" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="-" start="108098332" stop="108236255" variantLength="137924" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="167000" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment>This is a full deletion of ATM. This whole gene deletion was detected by next generation sequencing of genomic DNA (gDNA) and confirmed by MLPA.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB9611268</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3425759" TraitType="Disease" MappingType="XRef" MappingValue="167000" MappingRef="OMIM">
        <MedGen CUI="C1140680" Name="Ovarian cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3425761" TraitType="Disease" MappingType="XRef" MappingValue="C0854924" MappingRef="MedGen">
        <MedGen CUI="C0854924" Name="Endometrial serous adenocarcinoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3425761" TraitType="Disease" MappingType="XRef" MappingValue="C0032463" MappingRef="MedGen">
        <MedGen CUI="C0032463" Name="Acquired polycythemia vera" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

